Rezolute, Inc. (NASDAQ:RZLT – Get Free Report) Director Young-Jin Kim acquired 1,230,769 shares of the business’s stock in a transaction dated Friday, June 13th. The stock was acquired at an average price of $3.25 per share, for a total transaction of $3,999,999.25. Following the purchase, the director now directly owns 8,423,386 shares of the company’s stock, valued at approximately $27,376,004.50. This trade represents a 17.11% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
Rezolute Stock Performance
Shares of NASDAQ RZLT opened at $4.33 on Thursday. The company has a market capitalization of $370.30 million, a PE ratio of -3.77 and a beta of 1.04. The company’s fifty day moving average price is $3.92 and its 200 day moving average price is $4.09. Rezolute, Inc. has a 1 year low of $2.22 and a 1 year high of $6.19.
Rezolute (NASDAQ:RZLT – Get Free Report) last issued its quarterly earnings data on Tuesday, May 13th. The company reported ($0.27) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.22) by ($0.05). On average, equities analysts expect that Rezolute, Inc. will post -0.93 EPS for the current year.
Wall Street Analyst Weigh In
Read Our Latest Stock Analysis on Rezolute
Hedge Funds Weigh In On Rezolute
Institutional investors and hedge funds have recently modified their holdings of the business. Man Group plc purchased a new position in Rezolute during the fourth quarter worth approximately $425,000. Geode Capital Management LLC grew its stake in Rezolute by 5.2% in the 4th quarter. Geode Capital Management LLC now owns 517,014 shares of the company’s stock valued at $2,535,000 after acquiring an additional 25,413 shares during the period. Ameriprise Financial Inc. purchased a new stake in Rezolute in the 4th quarter worth $342,000. Barclays PLC acquired a new position in Rezolute during the fourth quarter worth $314,000. Finally, Nantahala Capital Management LLC raised its position in Rezolute by 10.9% during the fourth quarter. Nantahala Capital Management LLC now owns 2,857,982 shares of the company’s stock worth $14,004,000 after acquiring an additional 280,861 shares during the period. Hedge funds and other institutional investors own 82.97% of the company’s stock.
About Rezolute
Rezolute, Inc, a clinical stage biopharmaceutical company, develops therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder.
Featured Articles
- Five stocks we like better than Rezolute
- What is diluted earnings per share (Diluted EPS)?
- Top 3 Bank Stocks to Watch as Fed Rate Cuts Loom
- Buy P&G Now, Before It Sets A New All-Time High
- Uber and Tesla Surge on Robotaxis, Analyst Touts Texas Rides
- Profitably Trade Stocks at 52-Week Highs
- ASML Keeps Buying Back Its Own Stock—Chasing Discount and Upside
Receive News & Ratings for Rezolute Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rezolute and related companies with MarketBeat.com's FREE daily email newsletter.